BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7274558)

  • 1. Clinical experience with 120,000 units of modified fluid gelatin.
    Lundsgaard-Hansen P; Tschirren B
    Dev Biol Stand; 1980; 48():251-6. PubMed ID: 7274558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of gelofusin in the clinics of the St. Petersburg's I.P. Pavlov State Medical University].
    Baryshev BA; Doĭnikov DN; Khabarova IG; Kovalev MG
    Vestn Khir Im I I Grek; 1998; 157(2):51-4. PubMed ID: 9691382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Practical experience with Physiogel as blood substitute].
    Tschirren B; Pfistner P
    Helv Chir Acta; 1966 May; 33(3):404-14. PubMed ID: 5994660
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reducing of unwanted side effects of modified fluid gelatin by promethazine: controlled clinical trial with orthopaedic patints (author's transl)].
    Schöning B; Koch H
    Anaesthesist; 1981 Jan; 30(1):34-43. PubMed ID: 7469003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative trials of fluid gelatins on hemostasis in heart surgery in adults].
    Charlet P; Zerr C; Robert D; Merville C; Renouf P; Khayat MC
    Cah Anesthesiol; 1991; 39(4):233-8. PubMed ID: 1933520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of the efficacy and tolerability of 2 plasma substitutes used as vascular-loading solutions during plasma exchange].
    Bombail-Girard D; Boulechfar H; Tangre M; Landillon N; Bussel A
    Ann Med Interne (Paris); 1990; 141(7):611-4. PubMed ID: 2085241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience with a blood component program in surgical hemotherapy].
    Lundsgaard-Hansen P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(6):933-42. PubMed ID: 6187647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock.
    Upadhyay M; Singhi S; Murlidharan J; Kaur N; Majumdar S
    Indian Pediatr; 2005 Mar; 42(3):223-31. PubMed ID: 15817970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [1st clinical trial of a new high-molecular-weight, gelatin-based plasma substitute].
    Scholz PM; Rittmann WW; Müller W; Leutenegger A; Gruber UF
    Schweiz Med Wochenschr; 1971 Jul; 101(27):987-94. PubMed ID: 5169067
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative effects of fluid gelatins on bleeding during heart surgery in the adult].
    Zerr C; Lebreton P; Merville C; Nivaud M; Kaladji C; Khayat A
    Cah Anesthesiol; 1988 Nov; 36(7):527-32. PubMed ID: 3214778
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anaphylactoid reaction to Physiogel SRK 4%--a contribution to the controversy about plasma substitutes].
    Cron TA; Gerber H
    Schweiz Med Wochenschr; 1991 Nov; 121(48):1773-6. PubMed ID: 1688371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical studies on possible side effects of a plasma substitute on the basis of gelatin (in spinal anesthesia)].
    Neumann R
    Infusionsther Klin Ernahr; 1975 Oct; 2(5):353-4. PubMed ID: 1184183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical plasma substitution with gelatin: A 12-year experience with 39,320 units of Physiogel].
    Tschirren B; Affolter U; Elsässer R; Frehofer UA; Grawehr R; Müller PH; Lundsgaard-Hansen P
    Infusionstherapie (1973); 1974 Dec; 1(8):651-62. PubMed ID: 4142946
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood volumes, plasma volumes and total plasma albumin after human blood-loss substitution with physiogel, macrodex 6 and 1,8 dextran-Ringer-lactate].
    Schaer H; Kundert HP; Hossli G
    Bibl Haematol; 1971; 37():329-35. PubMed ID: 5138918
    [No Abstract]   [Full Text] [Related]  

  • 15. [Modezhel' erythrocyte preservative as an experimental and clinical blood substitute].
    Selivanov EA; Mel'nikova VN; Kochetygov NI; Pleshakov VT; Gerbut KA; Krivtsova IM; Lur'e GO
    Vestn Khir Im I I Grek; 1996; (1):71-4. PubMed ID: 8753967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Component therapy of surgical hemorrhage: red cells, plasma substitutes and albumin.
    Lundsgaard-Hansen P; Pappova E
    Ann Clin Res; 1981; 13 Suppl 33():26-38. PubMed ID: 7342841
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental studies on modified fluid gelatin as a plasma substitute. 1].
    Tosaki Y; Asumi N; Takaori M
    Masui; 1968 Apr; 17(4):323-30. PubMed ID: 5692009
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intraoperative anaphylactic/anaphylactoid reaction to infusion of a modified liquid gelatin].
    Israelian LA; Lubnin AIu
    Anesteziol Reanimatol; 2004; (2):36-40. PubMed ID: 15206275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infusiontherapy with colloidal volumesubstitutes (author's transl)].
    Ring J; Messmer K
    Anaesthesist; 1977 Jun; 26(6):279-87. PubMed ID: 883609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodilution, oxygen consumption, and recovery from surgical shock. --A study on the efficacy of different plasma substitutes.
    Dawidson I
    Ann Clin Res; 1981; 13 Suppl 33():44-7. PubMed ID: 7342843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.